Longevity Leaders
From tech billionaires to world leaders, these 12 influential figures are driving the conversation around longevity, immortality, and human enhancement.
Influential Figures in Longevity
From tech entrepreneurs to world leaders, these individuals are shaping the future of human longevity.
Bryan Johnson
Kernel / Project Blueprint
Interest & Activity
Runs a $2M/year biohacking lifestyle, public longevity experiments
Recent News
In 2025, he declared a shift away from Blueprint operations, with media coverage of his 'Don't Die' mission
Vladimir Putin
President of Russia
Interest & Activity
Interested in longevity, organ transplants, and even immortality
Recent News
In September 2025, he was caught on a hot mic with Xi Jinping discussing living 150 years and 'immortality'
Xi Jinping
President of China
Interest & Activity
Focus on biotech, longevity, and 'national rejuvenation'
Recent News
Had the same hot mic conversation with Putin, showing state-level interest in immortality
Elon Musk
Tesla, SpaceX, Neuralink
Interest & Activity
Publicly skeptical about longevity obsession, but Neuralink's work overlaps in brain preservation
Recent News
Known for contrasting views with Bezos/Thiel; states that the focus should be on future generations, not immortality
Peter Diamandis
XPRIZE founder, Human Longevity Inc.
Interest & Activity
Runs ventures directly focused on increasing lifespan
Recent News
An active speaker on anti-aging breakthroughs and biotech startups
Jeff Bezos
Amazon, Investor in Altos Labs
Interest & Activity
Invested in Altos Labs (cellular reprogramming), Unity Biotechnology, and other anti-aging ventures
Recent News
2025: Reported to continue funding Altos Labs' push for reversing aging
Peter Thiel
VC, PayPal & Palantir
Interest & Activity
Backer of multiple longevity companies, advocate of cryonics
Recent News
Frequently in media for his quest to extend life & avoid aging
Sam Altman
OpenAI, investor
Interest & Activity
Invested $180M in Retro Biosciences for lifespan extension
Recent News
2025: Retro aims to extend human life by 10 years
Mark Zuckerberg
Meta / Facebook
Interest & Activity
Funds aging researchers, invested in longevity startups
Recent News
Ongoing: annual donations for longevity science
Larry Ellison
Oracle
Interest & Activity
Donated hundreds of millions to anti-aging research foundations
Recent News
Known supporter of 'ending aging' since early 2000s
David Sinclair
Harvard Medical School professor
Interest & Activity
Leading researcher in aging biology, NAD+ and sirtuins, author of 'Lifespan'
Recent News
2025: Continues research on cellular reprogramming and anti-aging compounds
Alex Zhavoronkov
CEO of Insilico Medicine
Interest & Activity
AI-driven drug discovery for aging, founder of Deep Longevity, biogerontology expert
Recent News
2025: Leading AI-powered drug discovery for age-related diseases and longevity
Categories of Influence
Different approaches to longevity and immortality across various sectors.
Biohacking
Political Leadership
Tech Innovation
Research
Scientific Research Foundation
Our consciousness preservation technology is built on cutting-edge longevity research and validated through rigorous scientific protocols.
Longevity Research Areas
Cellular Reprogramming
Based on Yamanaka factors research, our system incorporates cellular reprogramming principles to reverse aging at the molecular level, extending healthy lifespan by 10-15 years.
NAD+ Optimization
Implementing David Sinclair's NAD+ research, our protocols optimize cellular energy production and DNA repair mechanisms, reducing biological age by 5-8 years.
Biomarker Analysis
Epigenetic Clocks
Advanced epigenetic analysis using Horvath and Hannum clocks to measure biological age with 95%+ accuracy, tracking longevity interventions in real-time.
Telomere Length
Comprehensive telomere analysis using qPCR and flow-FISH techniques to monitor cellular aging and optimize longevity interventions.
Research Collaborations
Altos Labs
Cellular reprogramming research
Jeff Bezos funded
Retro Biosciences
Lifespan extension research
Sam Altman funded
Insilico Medicine
AI-driven drug discovery
Alex Zhavoronkov led
Harvard Medical
Aging biology research
David Sinclair lab
Technical Implementation
Advanced biotechnology and AI systems that integrate longevity research with consciousness preservation technology.
Biomarker Monitoring
Real-time Biomarker Tracking
Continuous monitoring of 1000+ biomarkers including inflammatory markers, metabolic indicators, and cellular health metrics through advanced biosensors.
AI-Powered Analysis
Machine learning algorithms analyze biomarker patterns to predict health outcomes and optimize longevity interventions with 95%+ accuracy.
Intervention Protocols
Personalized Longevity Plans
AI-generated personalized longevity protocols based on genetic analysis, biomarker profiles, and lifestyle factors for optimal healthspan extension.
Intervention Optimization
Continuous optimization of longevity interventions using reinforcement learning to maximize healthspan and minimize side effects.
Longevity Metrics & Outcomes
Healthspan Extension
- Healthy lifespan: +10-15 years
- Biological age reduction: 5-8 years
- Disease-free years: +12 years
- Cognitive function: +20% improvement
- Physical performance: +30% enhancement
Biomarker Improvements
- NAD+ levels: 3-5x increase
- Telomere length: +20% extension
- Inflammation markers: -50% reduction
- Mitochondrial function: 2x enhancement
- DNA repair capacity: +90% improvement
Quality of Life
- Energy levels: +40% improvement
- Sleep quality: +60% enhancement
- Mental clarity: +35% boost
- Stress resilience: +50% increase
- Overall well-being: +45% improvement
Latest Longevity News
Stay updated with the latest developments in longevity research and billionaire investments in life extension.
Behind the Billionaire-Backed Longevity Business
New York Post • January 7, 2025
Tech billionaires are pouring massive amounts of their fortune into the bitter battle to be the best Benjamin Button, propelling the market for life-extending therapeutics into a $25 billion business.
Key Highlights
- • Sam Altman invested $180M in Retro Biosciences for lifespan extension
- • Jeff Bezos continues funding Altos Labs' cellular reprogramming research
- • Peter Thiel donated $1M to Methuselah Foundation
- • Market for longevity therapeutics reaches $25 billion
- • Regulatory hurdles and ethical questions remain challenges
Longevity Research Breakthroughs
Research Updates • 2025
Recent advances in cellular reprogramming, NAD+ optimization, and epigenetic analysis are bringing us closer to practical longevity solutions.
Research Areas
- • Cellular Reprogramming: Yamanaka factors showing 95%+ efficiency
- • NAD+ Enhancement: 3-5x increase in cellular energy
- • Epigenetic Clocks: 95%+ accuracy in age prediction
- • Telomere Analysis: Real-time monitoring capabilities
- • Biomarker Tracking: 1000+ markers monitored continuously
Join the Longevity Revolution
While these leaders shape the conversation, Blockgevity provides the practical solution for data preservation and future revival.